Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neutralizing epitopes of RSV and palivizumab resistance in Japan.

Fukushima journal of medical science - 19 Dec 2017

Hashimoto Koichi, Hosoya Mitsuaki

Abstract excerpt

Respiratory Syncytial Virus (RSV) is one of the most important viral pathogen related to acute lower respiratory infection in young children. The virus surface envelope contains the G, F, and SH proteins as spike proteins. The F protein is considered to be a major antigenic target for the neutralizing (NT) epitope as only the F protein is essential for cell infection among the three viral envelope proteins, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Resistance, Viral
Share to Epitopes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Neutralization Tests

Share to Respiratory Syncytial Viruses

Share to Viral Fusion Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 28867684
DOI: 10.5387/fms.2017-09
PMCID: PMC5792496

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neutralizing epitopes of RSV and palivizumab resistance in Japan.PMID 28867684Read ↗

Immune escaping of the novel genotypes of human respiratory syncytial virus based on gene sequence variation.Semantic proximity Read ↗

Amino Acid Substitutions in the Fusion Protein of Respiratory Syncytial Virus in Fukushima, Japan, During 2008–2023 and Their EffectsSemantic proximity Read ↗

Generation of novel respiratory syncytial virus vaccine candidate antigens that can induce high levels of prefusion-specific antibodies.Semantic proximity Read ↗

Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutants.Semantic proximity Read ↗

Molecular characterization of respiratory syncytial viruses infecting children reported to have received palivizumab immunoprophylaxis.Semantic proximity Read ↗

The long road to protect infants against severe RSV lower respiratory tract illnessSemantic proximity Read ↗

Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion proteinSemantic proximity Read ↗

Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract.Semantic proximity Read ↗

Cell fusion assay by expression of respiratory syncytial virus (RSV) fusion protein to analyze the mutation of palivizumab-resistant strains.Semantic proximity Read ↗

Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus.Semantic proximity Read ↗

Protective antigenic sites identified in respiratory syncytial virus fusion protein reveals importance of p27 domainSemantic proximity Read ↗

[Gene sequence and antigenic epitope variation within the F protein of respiratory syncytial virus in Sichuan, China].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.